Pharmaceuticals: Major
Polish companies operating in the same pharmaceuticals: major industry
The table below has Polish companies that operate under the same industry, pharmaceuticals: major. This list helps you analyze each company’s performance, income statements, and stock activity — all in one place. Sort by key metrics to find the most expensive stocks like Eli Lilly and Company, or spot the most traded options, such as Medicofarma Biotech Spolka Akcyjna. Ideal for investors and traders looking to build or refine a strategy within this growing tech segment.
Symbol | Mkt cap | Price | Chg % | Vol | Rel vol | P/E | EPS dil TTM | EPS dil growth TTM YoY | Div yield % TTM | Sector | Analyst rating |
|---|---|---|---|---|---|---|---|---|---|---|---|
 LILYEli Lilly and Company | 3.53 T PLN | 3,700.0 PLN | 0.00% | 4 | 3.08 | 35.87 | 103.16 PLN | +120.55% | 0.61% | Health technology | Strong buy |
 NVONovo Nordisk A/S Class B | 725.76 B PLN | 162.62 PLN | +0.77% | 18 | 0.02 | 10.36 | 15.70 PLN | +19.29% | 4.07% | Health technology | Neutral |
 BAYBayer AG | 161.07 B PLN | 160.95 PLN | 0.00% | 0 | 0.00 | — | −9.42 PLN | +32.17% | 0.29% | Health technology | Buy |
 KRKKrka, d. d., Novo mesto | 34.08 B PLN | 1,098 PLN | +1.10% | 11 | 0.14 | 20.92 | 52.49 PLN | −6.30% | 3.21% | Health technology | Buy |
 SPHSopharma AD | 4.04 B PLN | 7.42 PLN | 0.00% | 0 | 0.00 | 13.62 | 0.54 PLN | +55.43% | 3.17% | Health technology | No rating |
 CLNCelon Pharma SA | 1.11 B PLN | 20.90 PLN | +0.97% | 1.44 K | 0.21 | — | −1.47 PLN | −240.44% | 0.00% | Health technology | Neutral |
 RVURyvu Therapeutics SA | 527.14 M PLN | 22.70 PLN | −0.44% | 2.36 K | 0.15 | — | −4.38 PLN | +9.16% | 0.00% | Health technology | Buy |
 CTXCaptor Therapeutics SA | 493.02 M PLN | 76.4 PLN | −1.55% | 1.35 K | 0.57 | — | −7.62 PLN | +4.27% | 0.00% | Health technology | Strong buy |
 BCXBioceltix SA | 460.84 M PLN | 82.0 PLN | −1.56% | 1.36 K | 0.28 | — | −3.06 PLN | +10.77% | 0.00% | Health technology | Strong buy |
 BIOBIOTON S.A. | 370.07 M PLN | 4.220 PLN | −2.09% | 5.89 K | 0.09 | 106.84 | 0.04 PLN | — | 0.00% | Health technology | No rating |
 SVESYNTHAVERSE Spolka Akcyjna | 233.38 M PLN | 3.100 PLN | +0.98% | 8.38 K | 0.27 | — | −0.28 PLN | −357.92% | 0.00% | Health technology | No rating |
 MOCMolecure SA | 108.37 M PLN | 5.33 PLN | +1.33% | 4.06 K | 0.12 | — | −0.77 PLN | +60.21% | 0.00% | Health technology | Strong buy |
 MDTMedTech Solutions S.A. | 53.6 M PLN | 0.715 PLN | +0.70% | 48.81 K | 0.27 | — | −0.05 PLN | −48.70% | 0.00% | Health technology | No rating |
 BGDBiogened SA | 44.46 M PLN | 18.1 PLN | 0.00% | 1 | 0.02 | — | — | — | 5.52% | Health technology | No rating |
 MDBMedicofarma Biotech Spolka Akcyjna | 31.81 M PLN | 0.505 PLN | +7.91% | 91.68 K | 2.57 | — | −0.03 PLN | +3.24% | 0.00% | Health technology | No rating |
 SNGSYNERGA.fund SA | 12.26 M PLN | 0.450 PLN | +0.22% | 191 | 0.02 | — | — | — | — | Health technology | No rating |
| SS2BSyn2bio Spolka Akcyjna | — | 32.645 PLN | +1.70% | 5.01 K | 0.08 | — | — | — | — | Health technology | Strong buy |
 SCSStem Cells Spin SA | — | 0.440 PLN | 0.00% | 100 | 0.05 | — | — | — | — | Health technology | No rating |